BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

November Archive 2002

Simon Kerr joins TheraSci Board

Synoptics Receives Important Business Accolade A Highly Prized ‘Technology Fast 50’ Award

MERGER CREATES NEW FORCE IN SCIENCE-BASED COMMUNICATIONS

Autoscribe The productivity tool for every laboratory

French government will announce boost for innovation, SCI told

Biotech Tracker News - Forteo Approved 

Biotech Tracker News - Another Replagal Setback 

LeadDiscovery revolutionizes scientific surveillance with the launch of DailyUpdates

Interferon State of the Science and Strategic Opportunities

Parkinson's Disease State of the Science and Strategic Opportunities

ENACT PHARMA Appoint Evolution Beeson Gregory to Explore Options for Maximising Shareholder Value 

JPK Instruments AG Profitable with nanobiotechnology after only 6 months

Biotech Tracker News - Suboptimal Study Suggests Rebif Advantage Over Avonex 

Biotech Tracker News - Zavesca Approved in Europe 

BioTech Sage Report - small-capped biotechs in Phase II/III clinical trials, chemotherapy-induced nausea and vomiting (CINV)

Syngene - New Software and Image Analysis Range 

Aromatase Inhibitors in Breast Cancer State of the Science and Strategic Opportunities

AS Insights launch new report Insulin State of the Science and Strategic Opportunities

Biotech Tracker News - Aldurazyme Should be Approved 

17.5 billion Euro for the European Research Area - New biotechnology magazine elucidates European structures

Advanced Chemtech - Off-the-shelf peptide libraries

Biotech Tracker News - Zavesca's Second Chance Type I Gaucher disease

Cambridge Display Technology Tops Deloitte & Touche Eastern Technology Fast 50 List with 4,786% Turnover Growth

MORPHOCHEM SIGNS DEAL WITH ASTRAZENECA TO DEVELOP NOVEL ANTI-THROMBOTICS

JPK Instruments AG Nanotechnology for the Life Science Sector

CME TELEMETRIX ANNOUNCES THIRD QUARTER 2002 FINANCIAL RESULTS

Hemosol Receives Clearance from U.S. FDA to Initiate Study of HEMOLINK in Orthopedic Surgery 

Mediatum - Management Boutique at the Interface between Pharmaceutical and Biotech Industry

Biotech Tracker News - Study Supports BioBypass Development 

Biotech Tracker News - Onyx’s Raf Inhibitor Shows Promise 

Biotech Tracker News - Boston Scientific Presents Additional Coated Stent Data 

Biotech Tracker News - Treatment Regimen for Pexelizumab Starting to Take Shape 

Eli Lilly's Xigris: struggling to overcome its problems in the sepsis market

Hepatocellular carcinoma: pointing the way for other niche cancers

Biotech Tracker News - Xyotax Promising for Ovarian Cancer 

Morphochem’s lead programme orally available inhibitors of Factor xa identified in preclinical studies as potential novel antithrombotics

BioTech Sage Report - ReCap on BioGen, Celgene, ICOS, Genzyme, Imclone

Biotech Tracker News - FDA Committee Recommends Pegasys Copegus Combo 

GENOME express increases focus on integrated collaborative high throughput services and solutions

Genovac Products for Drug Development in Japan

Oxford Biomedica plc David Higgins appointed vice president for business development

NextGen Sciences Ltd (Huntingdon, Cambridgeshire, United Kingdom) is granted a patent for producing Protein BioChips

BioPortfolio Recruitment in the Biotechnology and Pharmaceutical Sectors

Biotech Tracker News - Prodrugs and Improved Drug Delivery for Parkinson Disease 

Synbiosis New ProtoCOL System For Faster, More Accurate Colony Count and Inhibition Zone Measurement 

Tm BIOSCIENCE CLOSES FINANCING OF $4.66 MILLION CAD

Biotech Tracker News - FDA Committee Will Review Pegasys - Copegus Combination 

Biotech Tracker News - Advantages of the Zevalin Therapeutic Regimen 

Genevac Automated solutions for solvent removal

ESA Analytical Determination of metanephrines aids in pheochromocytoma diagnosis …

AlphaRx Inc. Announces Letter of Intent with Select Therapeutics Inc. to Sub-license Cancer Therapeutic

The Harten Group - Specialist Interim Management Company Announces Major Expansion

AS Insights launch new report Erythropoietin State of the Science and Strategic Opportunities 

Biotech Tracker News - Hyseq ~ Variagenics Combined Company May Still Lack Critical Mass

Capsulution NanoScience AG MIT Expert for high-profile Advisory Board

Biotech Tracker News - No Label Expansion for Copaxone into PPMS 

Biotech Tracker News - Seattle Genetics’ Clinical Pipeline is Not Its Most Compelling Asset 

BioSeeker launches new report "Ion Channels as Therapeutic Targets for Multiple Diseases"

BioSeeker launches new report "New Targets and Drug Discovery Platforms in Antifungal R&D"

LeadDiscovery launch new pharmaceutical dossier "Glycogen synthase kinase 3 inhibitors: Proof of concept and therapeutic opportunities for the treatment of diabetes, Alzheimer's disease, stroke & bipolar disorder"

Oxford Biomedica plc update on cancer clinical plans

SmartBead Technology Cambridge firm tops again in international technology competition

QUEST LAUNCHES WORLD'S FIRST NON-ANIMAL-DERIVED INGREDIENT RANGE FOR BIOTECH MEDICINES

PiR Group: Qualified Persons (QPs) Have Never Had it So Good: Four-Wheeled Benefits and Base Salary Better Than Ever

Nonlinear Dynamics expands presence in Europe with new distributor in France

Frost & Sullivan Gives Competitive Strategy Award for Life-Science Mass Spectrometry Market to Bruker Daltonics, and CEO of the Year Award in Drug Discovery Tools to Frank Laukien 

Synoptics Honoured with Major SMART Award To Help Fund Development of a New Biological Imaging System

Compugen Announces Licensing of its Z4000 System for Proteomic Research to Organon and Procter & Gamble 

Catalyst BioMedica fund DanioLabs in the search for novel treatments for neurological and ophthalmic disorders

Syncroscopy New Version of Microscopy Software Rapidly Generates Complete Images of Large Samples

Biotech Tracker News - New Xigris Data Only a Beginning 

Biotech Tracker News - Bexxar Round II (iodine-131 tositumomab)

Biotech Tracker News - AMG073 Moves Forward 

Bruker Daltonics Reports Strong Growth in Revenue and Operating Income for the Third Quarter 2002 

Chiracon - Valuable starting materials and resources for the technical and pharmaceutical chemistry

Tm BIOSCIENCE announces coagulation test validation with 100% concordance to DNA sequencing

Cytomyx announces the acquisition of Cambridge BioScience

Advanced Chemtech - Flexible and productive Automated Peptide Synthesiser 

Synbiosis Automated Colony Counter is UKAS Accredited For Accurate Enumeration of Potentially Hazardous Microbes in Water

AGBIOS is excited to announce the release of Edition 2 of our highly acclaimed CD-ROM publication, Essential Biosafety

Licensing opportunity: adrenoceptor antagonists for sexual dysfunction

Launch of The Spilker report ™ Unique publication focuses on shortening drug development time 

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.